Withdrawal anxiety following chronic ethanol exposure is often associated with relapse in recovering alcoholics. It is likely that brain regions regulating anxiety-like behaviors adapt during chronic ethanol exposure to ultimately regulate such behaviors. The central amygdala contains numerous neurotransmitter systems that have been implicated in the regulation of anxiety-like behavior, including corticotropin releasing factor (CRF) and NMDA-type glutamate receptors. Chronic ethanol exposure causes functional adaptations in both CRF and NMDA receptors that are likely to regulate anxiety-like behaviors expressed during withdrawal. However, the molecular mechanisms governing these adaptations remain unexplored. We therefore evaluated these neurotransmitter systems in Sprague-Dawley rats during chronic ingestion of an ethanol-containing liquid diet. Quantitative real-time reverse transcription-PCR demonstrated that preproCRF mRNA was significantly upregulated by chronic ethanol exposure, whereas mRNA expression of CRF binding protein did not change. There were also no significant changes observed in any of the NMDA subunit mRNAs, although there was a trend toward greater NR2A mRNA expression during chronic ethanol exposure. Using Western blotting analysis we measured NMDA receptor subunit protein expression. Chronic ethanol exposure did not affect protein levels of the NR1 and NR2B subunits. Like the mRNA measures, chronic ethanol exposure did influence NR2A protein levels but the effects were modest. Our results demonstrate that NMDA receptor subunit mRNA and protein expressions are not strongly influenced by exposure to chronic ethanol. This suggests that the functional NMDA receptor adaptations identified in previous studies [Roberto, M., Schweitzer, P., Madamba, S. G., Stouffer, D. G., Parsons, L. H., & Siggins, G. R. (2004) . Acute and chronic ethanol exposure alter glutamatergic transmission in rat central amygdala: an in vitro and in vivo analysis. J Neurosci 24, 1594-1603] are likely to be mediated by post-translational events. In contrast, enhanced levels of CRF during/after chronic ethanol exposure are likely to be mediated by increased levels of prepro CRF mRNA. Together, our findings suggest that adaptations to chronic ethanol exposure by proanxiety factors expressed in the central nucleus appear to be mediated by distinct cellular and molecular mechanisms. Ó 2005 Elsevier Inc. All rights reserved.
Introduction
The amygdala receives highly processed sensory and cognitive information and projects to regions regulating risk assessment (e.g., medial prefrontal cortex, bed nucleus of the stria terminalis, nucleus accumbens) as well as autonomic responses to emotionally relevant environmental stimuli. This region consequently presents as a nexus for the regulation of affective behaviors like fear and anxiety. Indeed, direct manipulation of amygdala neurotransmitter systems can modulate basal anxiety-like behavior (Moller et al., 1997; Shibata et al., 1989) and disrupt conditioned fear learning (Killcross et al., 1997; Nader et al., 2001) . Recently, it has been demonstrated that various amygdala subdivisions modulate drug-seeking behaviors in rodents (Alderson et al., 2000; Di Ciano & Everitt, 2004; Fuchs & See, 2002; McLaughlin & See, 2003) , drug cravings in humans (Childress et al., 1999) , and the regulation of anxiety-like behaviors during withdrawal from chronic drug exposure (Menzaghi et al., 1994; Rodriguez de Fonseca et al., 1997; Watanabe et al., 2002) . These findings illustrate the importance of the amygdala in the regulation of both basal affective behaviors and those associated with chronic drug exposure.
The central nucleus of the amygdala has received particular attention with regard to anxiety-like behavior during withdrawal from chronic drug exposure. For example, corticotropin releasing factor (CRF) is a neuropeptide synthesized by neurons of the central amygdala (CeN) (Cassell et al., 1986) . CRF is released both locally within the CeN and at distant projection sites like the bed nucleus of the stria terminalis and the hypothalamus. CeN CRF is believed to play a principal role in the regulation of negative affect associated with drug withdrawal. There is a substantial elevation in extracellular CRF levels in the CeN following withdrawal from cocaine self-administration (Richter & Weiss, 1999) , antagonist-induced withdrawal from chronic cannabinoid (Rodriguez de Fonseca et al., 1997) and morphine (Heinrichs et al., 1995) exposure, and withdrawal in ethanol-dependent animals (Menzaghi et al., 1994) . Injection of CRF receptor antagonists into the CeN block anxiety-like responses to withdrawal from chronic ethanol (Rassnick et al., 1993) . These findings indicate an intimate association between elevated CRF levels and withdrawalinduced anxiety.
Along with CRF, glutamate signaling in the CeN is likely to play a significant regulatory role in this region's modulation of affective responses to drug withdrawal. Chronic ethanol exposure enhances glutamate release and has been associated with adaptations in subunit-specific contributions to NMDA receptor-mediated synaptic responses (Roberto et al., 2004) . Similar findings have been reported in the adjacent lateral/basolateral nuclei (Floyd et al., 2003) . In addition, NMDA receptor antagonists injected directly into the CeN block the robust anxiety-like behavior precipitated by naloxone-induced withdrawal from chronic morphine (Watanabe et al., 2002) . NMDA receptor activation can facilitate CRF release by CeN neurons (Cratty & Birkle, 1999) ; enhanced glutamate signaling in the CeN can increase CRF release at distinct sites (Gabr et al., 1995) . These findings together suggest that adaptations by CeN neurotransmitter systems, particularly NMDA receptors, are likely to play a significant role in the behavioral responses to withdrawal from chronic drug exposure, including chronic ethanol.
Despite substantial evidence of functional adaptations in CRF-and NMDA-mediated signaling during or following chronic ethanol exposure, the molecular events governing such alterations remain unclear. A detailed understanding of these mechanisms would offer a clearer explanation of the potential therapies that address the long-term consequences of alcohol abuse and withdrawal. We have therefore used molecular and cellular approaches to specifically examine the impact of chronic ethanol exposure on CeN NMDA and CRF systems.
Materials and methods

Animal procedures
All animal procedures were performed in accordance with the protocol approved by Wake Forest University School of Medicine Animal Care and Use Committee that was consistent with the NIH animal care and use policy. Male Sprague-Dawley rats (~120 g; Harlan, Indianapolis, IN) were singly housed and exposed to an 8-h-on/16-h-off light/dark cycle. After 4 days of acclimation to the housing facility/conditions, rats were introduced to a commercially available Lieber-DeCarli (Lieber & DeCarli, 1989) liquid diet (Bio-Serv, Frenchtown, NJ). The next day, all standard chow was removed, and rats were given only the control liquid diet (LD). Individuals were then divided into two groups: ''control'' animals that continued to receive the standard liquid diet over the entire experiment (n 5 18), and ''chronic ethanol'' animals (n 5 19) that received an isocaloric, ethanol-containing liquid diet. These latter rats were introduced to the ethanol diet by increasing the percentage of ethanol in the diet for 2-3 days. Ethanolexposed animals received 4-6% ethanol for 10-12 days. Levels of the ethanol-containing liquid diet were titrated to each individual such that total consumption of ethanol was maintained or escalated over the entire exposure period. During the chronic ethanol exposure, animals ingested 11.6 6 0.3 g$kg
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$day 21 ethanol from the liquid diet (n 5 19). Using a commercially available NAD/alcohol dehydrogenase assay (Diagnostic Chemicals Ltd., Oxford, CT), blood-alcohol levels were measured at the time of sacrifice in ''sentinel'' animals and were 153 6 13 mg/dl (n 5 9). These values are almost identical to our previously published reports (Floyd et al., 2003; McCool et al., 2003) .
On the final day of exposure, intoxicated animals were anesthetized with halothane and decapitated. Coronal brain slices of thickness 400 mm were prepared on a vibratome using ice-cold modified Ringer's solution (180 mM sucrose, 30 mM NaCl, 4.5 mM KCl, 1 mM MgCl 2 , 26 mM NaHCO 3 , 1.2 mM NaH 2 PO 4 , 10 mM D-glucose; bubbled constantly with 95% O 2 /5% CO 2 ) and placed in a tissue holder containing room-temperature standard Ringer's solution (94 mM NaCl replaces the 180 mM sucrose for a final [NaCl] of 124 mM) until use (~10 min). The CeN was immediately dissected, frozen rapidly on dry ice, and kept at 280 C until use. Different sets of animals were used to measure the effects of chronic ethanol ingestion on mRNA (n 5 8 controls and 9 ethanol exposed) and protein expression (n 5 10 controls and 10 ethanol exposed).
Preparation of RNA and real-time reverse transcription-PCR
Total RNA was isolated from frozen CeN according to published procedures (Floyd et al., 2003) . Genomic DNA was removed by digestion with DNase I, and RNA was quantified using spectrophotometry. Total RNA from the entire forebrain (Fb) of single chow-fed Sprague-Dawley rat was used to standardize expression levels of our target genes. Reverse transcription of total RNA was performed using random hexanucleotides; RNA was removed from the resulting cDNA by digestion with RNaseH. For real-time PCR, 2-5 ''ng equivalents'' of the cDNA mixture was combined with 9 mM primers, 0.25 mM probe, and 13 Universal PCR Master Mix (Applied Biosystems, Foster City, CA). The PCR reaction consisted of initial incubations at 50 C for 2 min followed by 95 C for 10 min; steps were 40 cycles of 95 C for 15 s followed by 60 C for 1 min. The ''relative standard curve'' method (Johnson et al., 2000) was used to compare expression levels of mRNAs between the control and chronic ethanol samples as previously described (Floyd et al., 2003 (Floyd et al., , 2004 . The expression level of each subunit was normalized to glyceraldehyde phosphate dehydrogenase (GAPDH) in the same sample.
Primers and probes for the various rat NMDA receptors subunits and GAPDH have been described elsewhere (Floyd et al., 2003) . Using public sequences from GenBank, primer/ probe sets were similarly designed from CRF (accession# M54987) and CRF binding protein (CRF-BP; accession# X58023) using PrimerExpress software (version 3.0, Applied Biosystems). These sets were (1) for CRF, 5# primer CCA GGG CAG AGC AGT TAG CT (nucleotide# 672-691), 3# primer GCA ACA TTT CAT TTC CCG ATA ATC (nucleotide# 724-747), and probe CAA GCT CAC AGC AAC AGG AAA CTG ATG G (nucleotide# 695-722); (2) for CRF-BP, 5# primer CAG CCA TGT CAC CGA ACT TCA AAC (nucleotide# 113-136), 3# primer AAA GCA GGA AAG GGT CGT AGA CTG (nucleotide# 212-235), and probe ATG CCA CTT CAC TCT GAT CCT CCT GA (nucleotide# 141-166). All probes were 5#-labeled with 6-FAM, 3#-labeled with BHQ1, and purified with HPLC by the manufacturer (Integrated DNA Technologies, Coralville, IA).
Western blot analysis
Lysis buffer (10 mM Tris pH 7.5, 2% sodium dodecyl sulfate, 2 mM dithiothreitol) was added to isolated CeN at 10 ml/mg tissue, and tissue was disrupted by brief sonication. Protein yield was quantified using the BCA assay (Pierce Chemical, Rockford, IL). Ten to twenty micrograms of total protein was loaded onto 4-15% sodium dodecyl sulfate-polyacrylamide precast gels (Bio-Rad, Hercules, CA), separated, and transferred to a nitrocellulose membrane (Hybond N; Amersham, Piscataway, NJ). The membrane was blocked with phosphate buffered saline (PBS)-T (150 mM NaCl, 5.2 mM Na 2 HPO 4 , 1.7 mM KH 2 PO 4 , 0.1% Tween-20) containing 5% nonfat dry milk. Blots were then incubated overnight at 4 C in PBS-T/1% milk containing primary antibody that recognizes all NR1 subunits (''NR1-pan'' antibody, 0.5 mg/ml; Chemicon, Temecula, CA), NR1 subunits containing the NR1-C1 splice cassette (1 mg/ml; BD Pharmingen, San Jose, CA), NR2A subunit proteins (1:4,000; Chemicon), or NR2B subunit proteins (1:4,000; Chemicon). The next morning, blots were washed extensively with PBS-T and exposed to goat antirabbit or goat antimouse secondary antibodies labeled with peroxidase (1:3,000; SIGMA, St. Louis, MO) for several hours at room temperature. Detection of bound secondary antibody was performed using enhanced chemiluminescence (Pierce, Rockford, IL). To normalize expression between experiments, blots were also probed with mouse monoclonal antibody directed against b-actin (1:10,000; Chemicon) followed by peroxidase-labeled goat antimouse secondary antibody (1:3,000 dilution; Sigma). Band intensity was quantified from digital images of x-ray film using standard procedures (Jiang et al., 2002) .
Data analysis and statistics
For both mRNA and protein studies, mean expression levels were determined from two to three independent experiments for each sample. Average values from these experiments are reported as mean 6 S.E.M. (standard error of the mean) Statistical comparisons between each treatment group were performed with the standard Student's t test (Motulsky, 1995) .
Results
Chronic ethanol ingestion upregulates mRNA levels for some proanxiety factors
To assess whether neurotransmitter systems in brain regions regulating anxiety-like behavior adapt during chronic ethanol exposure, we measured the mRNA expression of several ''proanxiety'' factors in the CeN derived from control and chronic ethanol-exposed animals. CRF expressed in the CeN has been extensively characterized as a central regulatory component controlling anxietylike behavior (Rassnick et al., 1993; Richter et al., 2000; Rodriguez de Fonseca et al., 1997; Sajdyk et al., 1999) . Importantly, the expression of prepro CRF mRNA was significantly increased following chronic ethanol exposure. Normalized relative expression was 6.38 6 0.22 in CeN from control animals (n 5 7) and 7.99 6 0.66 in ethanolexposed CeN ( Fig. 1B ; P !.05, t test). This corresponds to a 25% increase during the chronic ethanol exposure. Because the biological activity of CRF is tightly controlled by CRF-BP (Behan et al., 1995; Ungless et al., 2003) , we also examined the impact of chronic ethanol on this gene product. The mRNA expression levels for CRF-BP were not significantly altered by chronic exposure to ethanol with relative levels being 1.3 6 0.1 in control amygdala tissue and 1.4 6 0.2 in ethanol-treated animals ( Fig. 1C ; P O.05, t test). Importantly, chronic ethanol exposure also did not significantly influence GAPDH mRNA levels: 2.4 6 0.4 in control samples and 2.2 6 0.5 in CeN (Fig. 1D) . These latter findings demonstrate that normalization of target gene levels to GAPDH did not produce any treatment-specific bias.
Because of functional adaptations by CeN NMDA receptors during chronic ethanol exposure (Roberto et al., 2004) , we also examined the influence of chronic ethanol ingestion on the expression of NMDA receptor subunit mRNAs (Table 1) . Unlike prepro CRF, this treatment did not significantly affect mRNA levels for the NMDA receptor subunits. In fact, the change in mRNA levels was less than 10%. However, the expression of some subunit mRNAs was characterized by substantial animal-to-animal variance. Indeed, although there was an apparent 20% increase in NR2A expression during chronic ethanol exposure, this variance prevented detection of a significant effect in this set of animals. These findings suggest that mRNAs for different proanxiety neurotransmitter systems in the CeN are uniquely modulated by chronic ethanol ingestion.
Chronic ethanol ingestion differentially regulates NMDA receptor subunit proteins
Because changes in NR2A contribution to the functional NMDA receptor might have meaningful implications for glutamate signaling in the CeN, we chose to examine the expression of NMDA receptor subunit proteins. For the NR1-pan, NR1-C1, NR2A, and NR2B subunit proteins, we normalized apparent expression levels to b-actin expression in each sample to reduce the influence of sample-to-sample differences in quality and control for errors in quantification or sample loading. Importantly, chronic ethanol exposure did not significantly influence b-actin-like immunoreactivity across all our experiments. Across all experiments, levels of b-actin were 334 6 38 optical density units in control samples (n 5 10) and 337 6 35 OD units in ethanol-exposed samples (n 5 10). For the NMDA subunits, chronic ethanol ingestion did not significantly alter protein levels. NR1 subunits containing the C1 C-terminal splice cassette were unaffected by chronic ethanol, with normalized expression The expression of prepro CRF mRNA is significantly increased during chronic ethanol exposure. Relative expression units were determined by dividing the apparent levels of prepro CRF mRNA by the apparent levels of GAPDH expression in each sample (see Section 2). *P ! .05, two-sided Student's t test. (C) The expression of CRF binding protein mRNA was not significantly affected by chronic ethanol exposure. (D) Chronic ethanol ingestion did not influence the expression of GAPDH in these experiments. Relative expression levels were therefore not significantly influenced by the normalization of target gene expression to GAPDH in each sample. being 4.26 6 0.18 in control CeN and 4.44 6 0.18 in ethanolexposed tissue ( Fig. 2B ; P O.05, t test; n 5 10 in each treatment group). In a subset of animals, normalized levels of total NR1 subunit protein ( Fig. 2A) were 2.21 6 0.07 in control CeN (n 5 6) and 2.08 6 0.18 in CeN from ethanolexposed animals (n 5 5; P O.05, Student's t test). Levels of NR2A subunit protein tended to be increased by chronic ethanol exposure, from 2.21 6 0.07 normalized units in control samples to 2.50 6 0.13 units during ethanol (13% increase, Fig. 2C ; P~.06, t test). Levels of NR2B-like immunoreactivity were not significantly influenced by chronic ethanol ingestion: 1.32 6 0.09 normalized units in controls vs. 1.38 6 0.11 in ethanol-exposed CeN samples ( Fig. 2D ; P O.05, test). These findings suggest that different NMDA receptor subunit proteins may be uniquely regulated by chronic alcohol. Furthermore, the modest upregulation of NR2A-like immunoreactivity during this exposure is consistent with the apparent changes in mRNA expression for this subunit.
Discussion
One of the central findings of this report is the chronic ethanol-induced upregulation of prepro CRF mRNA. Chronic ethanol enhances basal levels of CRF in CeN dialysates during both the exposure and acute withdrawal (!24 h) (Merlo Pich et al., 1995) . In addition, increased amygdala CRF tissue content is maintained several weeks after withdrawal (Zorrilla et al., 2001) . The upregulated prepro CRF mRNA reported here could clearly provide the mechanistic basis for increased CRF release during withdrawal from acute and chronic ethanol, although the contribution of this mechanism to longer lasting alterations in amygdala CRF is less clear. Similar effects have been noted in the bed nucleus of the stria terminalis (Olive et al., 2002) , a primary output area for CRF-containing neurons in the CeN. Enhanced prepro CRF expression in the CeN could contribute significantly to chronic ethanol-induced alterations of CRF peptide in numerous brain regions.
It is also noteworthy that CRF and CRF-BP were differentially regulated by chronic ethanol. CRF-BP is believed to be a negative regulator of ACTH secretion by clearing ''free'' CRF (Behan et al., 1995) and preventing CRF's positive influence on ACTH. However, some reports indicate that the CRF/CRF-BP complex may itself be the active ligand for CRF-R2 receptors (Ungless et al., 2003) . This requirement for a CRF/CRF-BP interaction suggests that chronic ethanol-induced increases in CRF expression, but not CRF-BP, would enhance physiological processes regulated by free CRF, presumably mediated by high affinity CRF-R1 receptors (Myers et al., 1998) . This hypothesis is supported by alcohol-induced upregulation of CRF-R1 expression in the hypothalamus (Lee & Rivier, 1997) , a structure that also receives significant CRFinnervation from the CeN. Finally, CRF-R2 agonists can attenuate the pronounced increase in anxiety-like behavior following withdrawal from chronic ethanol (Valdez et al., 2004) . Our CRF findings lend support to the hypothesis that chronic ethanol may disrupt the balance between CRF-R1-and CRF-R2-mediated events, which could in turn contribute to the disregulation of anxiety-like behaviors during withdrawal.
The mechanisms governing ethanol-induced upregulation of prepro CRF mRNA are not clear at present. In fact, very little is known regarding the transcriptional regulation of this gene in general. Glucocorticoids mediate robust negative regulation of hypothalamic CRF expression (Ma et al., 2001) . These interactions might suggest that stress hormones could regulate the response of prepro CRF to chronic ethanol. However, there is conflicting evidence regarding the effects of chronic ethanol on resting levels of corticosterone (Guaza et al., 1983; Rasmussen et al., 2000) . Despite these contrasting reports, chronic exposure can blunt both circadian cycling of corticosterone (Sipp et al., 1993) and the responsiveness of the hypothalamic-pituitaryadrenal (HPA) axis to external stressors (Ogilvie et al., 1998) . These findings suggest that chronic ethanol's interaction with the HPA axis may be relatively subtle. Subsequently, the role played by circulating glucocorticoids in the regulation of prepro CRF mRNA expression, particularly in response to chronic drug exposure, remains unclear.
Our findings also provide the first measures of NMDA subunit distribution in the CeN. NR1, NR2A, and NR2B mRNAs were readily detected in total RNA prepared from this brain region. In addition, if one assumes approximately equivalent efficiencies for the various subunit PCR reactions, the threshold cycle (C t ) values for each subunit ( Table 1) would suggest that the relative abundance of NMDA receptor subunit mRNAs in the CeN would be NR1 5 NR2B O NR2A [ NR2C 5 NR3A O NR3B O NR2D. This is consistent with recent reports suggesting that the NR2B-containing receptors contribute significantly to adult CeN NMDA receptor-mediated synaptic responses (Sah & Lopez De Armentia, 2003) . The differences between subunit C T values in the CeN samples (Table 1) would further suggest that NR2A, NR2C, and NR3A subunit mRNAs are relatively less abundant in the CeN compared to that in the Fb. Conversely, despite its low expression in comparison to the other NMDA receptor subunits, the NR2D subunit mRNA is relatively more abundant in the CeN compared to that in the Fb. The distribution of the various NMDA receptor subunits across the distinct CeN subdivisions and within phenotypically unique CeN neuronal populations remains to be determined.
Although we do not yet know if the adaptations reported here are directly associated with functional alterations in the NMDA receptor, this is likely to be the case. Roberto et al. (2004) recently reported that chronic exposure to ethanol vapor increases ifenprodil and ethanol inhibition of NMDA-mediated excitatory postsynaptic currents in CeN preparations, consistent with functional alterations in synaptic receptors containing the NR2B subunit. It is possible that the apparent upregulation in NR2A expression following chronic ingestion of an ethanol-containing liquid diet reported here is particular to this exposure paradigm. Indeed, more robust ethanol exposures may accentuate the effects on NR2A reported here and could potentially influence additional subunits as well. Despite this, it would be difficult to characterize functional adaptations in this subunit. NR2A-specific ligands are difficult to use in slice recordings, and the distinct biophysical characteristics bestowed by this subunit are likely to be masked by the expression of multiple NR2 subunits in this brain region. Although we did not find any evidence of adaptations in NR2B subunit mRNA or protein expression, chronic ethanol exposure of hippocampal neurons in vitro alters the localization of NR2B-containing NMDA receptors away from somatic compartments to synaptic sites (Carpenter-Hyland et al., 2004) . Along with increased ifenprodil sensitivity of NMDA-mediated synaptic responses following chronic ethanol inhalation (Roberto et al., 2004) , these findings together suggest that the mechanisms governing NMDA receptor adaptations to chronic ethanol exposure may be distinct for each subunit and can include alterations in both gene transcription/ translation and receptor localization. When considered in conjunction with apparent brain region-specific adaptations, the effects of chronic ethanol on the NMDA receptor are likely to be complex.
The CeN joins an expanding list of brain regions that respond to chronic ethanol exposure by upregulating NMDA receptor function and/or expression. Chronic ethanol also increases MK801 binding in related brain regions like the striatum (Gulya et al., 1991) . And, we have recently demonstrated that increased NR1 mRNA expression is associated with functional increases in the apparent density of NMDA receptors expressed by acutely isolated neurons from the neighboring lateral/basolateral amygdala (Floyd et al., 2003) . Together with a recent demonstration of increased glutamate release in the CeN following chronic ethanol exposure (Roberto et al., 2004) , these findings suggest increased glutamate signaling throughout the major amygdaloid subdivisions. Given the wellestablished role of the amygdala in the learning and expression of fear-like or anxiety-like behaviors, we believe these NMDA receptor adaptations may be directly related to the complex and important relationship between withdrawal-induced anxiety and alcohol abuse. In support of this, NMDA receptor antagonists injected directly into the CeN can block the acquisition of learned fear (Goosens & Maren, 2003) and also aversive behaviors associated with withdrawal from chronic opiate exposure (Watanabe et al., 2002) . Coincident adaptations in CRF expression and glutamate signaling are likely to play a significant role in such behaviors, including ethanol withdrawal-induced anxiety.
